90 related articles for article (PubMed ID: 9260597)
1. First-line chemotherapy of advanced breast cancer with a combination of mitoxantrone, methotrexate, and vincristine (MIMO).
Samonis G; Bafaloukos D; Margioris AN; Katsarma G; Toloudis P; Bacoyannis C; Karvounis N; Georgoulias V; Kosmidis P
Oncology; 1997; 54(5):371-5. PubMed ID: 9260597
[TBL] [Abstract][Full Text] [Related]
2. First-line combination chemotherapy with mitoxantrone, methotrexate, vincristine and carboplatin (MIMOC) in advanced breast cancer.
Bafaloukos D; Samonis G; Klinaki A; Daliani D; Karvounis N; Bacoyiannis C; Karabelis A; Milonakis N; Kosmidis P
Eur J Cancer; 1993; 29A(6):851-3. PubMed ID: 8484975
[TBL] [Abstract][Full Text] [Related]
3. First-line treatment with mitoxantrone, methotrexate, vincristine, and carboplatine (MIMOC) plus cyclical hormonotherapy with tamoxifen and megestrol acetate in advanced breast cancer.
Kakolyris S; Samonis G; Koukourakis M; Vlachonicolis J; Kalbakis K; Agelaki S; Chalkiadakis G; Sanidas E; Tsiftsis D; Georgoulias V
Am J Clin Oncol; 1999 Jun; 22(3):273-7. PubMed ID: 10362335
[TBL] [Abstract][Full Text] [Related]
4. Intensive chemotherapy with cisplatin, mitoxantrone, methotrexate and vincristine in metastatic breast cancer.
Queirolo P; Repetto L; Gardin G; Miglietta L; Guido T; Pronzato P; Rosso R
J Chemother; 1991 Jun; 3(3):194-7. PubMed ID: 1919659
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy with methotrexate, carboplatin, mitoxantrone (Novantrone) and vincristine (Oncovin) in transitional-cell urothelial cancer.
Pectasides D; Mylonakis A; Antoniou F; Kostopoulou M; Triantaphyllis D; Papadopoulou M; Varthalitis J; Dimitriadis M; Athanassiou A
Oncology; 1998; 55(2):139-44. PubMed ID: 9499188
[TBL] [Abstract][Full Text] [Related]
6. MMM (mitomycin/mitoxantrone/methotrexate): an effective new regimen in the treatment of metastatic breast cancer.
Smith IE; Powles TJ
Oncology; 1993 Apr; 50 Suppl 1():9-15. PubMed ID: 8483562
[TBL] [Abstract][Full Text] [Related]
7. Four-step high-dose sequential chemotherapy with double hematopoietic progenitor-cell rescue for metastatic breast cancer.
Patrone F; Ballestrero A; Ferrando F; Brema F; Moraglio L; Valbonesi M; Basta P; Ghio R; Gobbi M; Sessarego M
J Clin Oncol; 1995 Apr; 13(4):840-6. PubMed ID: 7707109
[TBL] [Abstract][Full Text] [Related]
8. First-line chemotherapy of advanced breast cancer with mitoxantrone, cyclophosphamide and vincristine.
Bezwoda WR; Dansey R; Seymour L
Oncology; 1989; 46(4):208-11. PubMed ID: 2740063
[TBL] [Abstract][Full Text] [Related]
9. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
Hainsworth JD; Jolivet J; Birch R; Hopkins LG; Greco FA
Cancer; 1997 Feb; 79(4):740-8. PubMed ID: 9024712
[TBL] [Abstract][Full Text] [Related]
10. Mitoxantrone, mitomycin-C, methotrexate combination chemotherapy with radiotherapy and/or surgery in stage III (T4B, NO-2, M0) breast cancer.
Raina V; Sharma A; Deo SV; Shukla NK; Mohanty BK; Goel A; Rath GK
J Assoc Physicians India; 1998 Nov; 46(11):926-9. PubMed ID: 11229215
[TBL] [Abstract][Full Text] [Related]
11. Use of mitoxantrone-based combination chemotherapy regimens as first-line treatment for advanced breast cancer.
Bezwoda WR; Hesdorffer CS; Dansey RD
S Afr Med J; 1987 Oct; 72(7):465-7. PubMed ID: 3660150
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate, mitoxantrone, 5-fluorouracil and leucovorin in metastatic breast cancer patients.
Merlini L; Secondo V; Mammoliti S; Bellotti P; Castello C; Gallo L
Anticancer Res; 1994; 14(3B):1423-6. PubMed ID: 8067717
[TBL] [Abstract][Full Text] [Related]
13. Mitoxantrone, methotrexate, and 5-fluorouracil combination chemotherapy as first-line treatment in stage IV breast cancer.
Bezwoda WR; Hesdorffer CS
Cancer; 1986 Jan; 57(2):218-21. PubMed ID: 3753656
[TBL] [Abstract][Full Text] [Related]
14. A pilot trial of TMM (thiotepa, mitoxantrone and methotrexate) chemotherapy for metastatic breast cancer.
Bhardwaj S; Holland JF
Ann Oncol; 1990 Nov; 1(6):443-4. PubMed ID: 2128030
[TBL] [Abstract][Full Text] [Related]
15. Mitoxantrone, methotrexate and chlorambucil in metastatic breast cancer, a combination with relatively low subjective toxicity.
Burghouts JT
Neth J Med; 1990 Feb; 36(1-2):43-5. PubMed ID: 2314519
[TBL] [Abstract][Full Text] [Related]
16. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy with a combination of mitoxantrone, methotrexate, 5-fluorouracil for node-positive breast cancer: phase II pilot study.
Kanno M; Nakamura S; Uotani C; Taniya T; Mura T; Bando H; Kawahara F; Tsugawa K; Noguchi M
J Chemother; 1999 Oct; 11(5):396-401. PubMed ID: 10632387
[TBL] [Abstract][Full Text] [Related]
18. Mitoxantrone (Novantrone) as single agent and in combination chemotherapy in the treatment of advanced breast cancer.
Smith IE; Stuart-Harris R; Pavlidis N; Bozek T
Cancer Treat Rev; 1983 Dec; 10 Suppl B():37-40. PubMed ID: 6661733
[TBL] [Abstract][Full Text] [Related]
19. Carboplatin (CBDCA), 5-fluorouracil (5-FU) and mitoxantrone (DHAD): an effective and well tolerated regimen for metastatic breast cancer.
Hidalgo OF; Gonzalez FG; Vieitez JM; Rebollo J; Tangco E; Herranz P
Ann Oncol; 1992 Jul; 3(7):545-7. PubMed ID: 1498075
[TBL] [Abstract][Full Text] [Related]
20. A phase I-II study of high-dose melphalan, mitoxantrone and carboplatin with peripheral blood stem cell support in patients with advanced ovarian or breast carcinoma.
Weaver CH; Greco FA; Hainsworth JD; Zhen B; Baldwin P; Wittlin F; Lewis M; West WH; Schwartzberg L; Buckner CD
Bone Marrow Transplant; 1997 Nov; 20(10):847-53. PubMed ID: 9404925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]